Petkau, J. M., & Eksteen, B. (2016). Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab. Biologics.
استشهاد بنمط شيكاغوPetkau, Jill MV, و Bertus Eksteen. "Selective Biologics for Ulcerative Colitis and Crohn’s Disease – Clinical Utility of Vedolizumab." Biologics 2016.
MLA استشهادPetkau, Jill MV, و Bertus Eksteen. "Selective Biologics for Ulcerative Colitis and Crohn’s Disease – Clinical Utility of Vedolizumab." Biologics 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.